Filter by: patients
Home > Community Treatment Reports and Side Effects > Adrenal Rebuilder Treatment Report
What is Adrenal Rebuilder?

Adrenal Rebuilder™ is said to provide naturally bioavailable building blocks to help support healthy adrenal structure and promote optimal function of adrenals and the other endocrine glands affected by stress.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Adrenal Fatigue 2 1 Efficacy_cant_tell
Hormone replacement 2 1 Efficacy_cant_tell
Other 1 0

See all 3 patients currently taking Adrenal Rebuilder

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 0
None
 2

Reported Dosages

  daily 6 daily 6 other daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Adrenal Rebuilder (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 50%
Expense 1   Expense: 50%
Course of treatment ended 1   Course of treatment ended: 50%

See all 2 patients who’ve stopped taking Adrenal Rebuilder

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Adrenal Rebuilder

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Adrenal Rebuilder

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Adrenal Rebuilder

Always
 1 50%
Usually
 1 50%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Adrenal Rebuilder

Very
 0 0%
Somewhat
 0 0%
A little
 2 100%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of Adrenal Rebuilder

$200+
 0 0%
$100-199
 0 0%
$50-99
 2 100%
$25-49
 0 0%
< $25
 0 0%

Report created on May 28, 2012.